HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshihiko Hoshida Selected Research

Valosin Containing Protein

11/2005Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer.
8/2004Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
7/2004Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma.
5/2004Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer.
2/2004Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
1/2004Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis.
1/2004Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms.
7/2003Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma.
2/2003Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshihiko Hoshida Research Topics

Disease

22Neoplasms (Cancer)
02/2011 - 01/2003
8Neoplasm Metastasis (Metastasis)
04/2018 - 02/2003
5Lymphatic Metastasis
11/2018 - 02/2004
4Rheumatoid Arthritis
06/2021 - 12/2005
4T-Cell Lymphoma (Lymphoma, T Cell)
01/2013 - 01/2003
4Carcinoma (Carcinomatosis)
07/2007 - 07/2003
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2007 - 03/2002
3Adenocarcinoma
06/2010 - 01/2004
3Hepatocellular Carcinoma (Hepatoma)
02/2006 - 02/2003
2Hyperplasia
06/2021 - 11/2002
2Inflammation (Inflammations)
06/2021 - 06/2007
2Colonic Neoplasms (Colon Cancer)
06/2010 - 01/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
09/2008 - 06/2007
2Thrombosis (Thrombus)
07/2008 - 01/2003
2Carcinogenesis
05/2006 - 04/2004
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
09/2004 - 01/2003
2Lung Neoplasms (Lung Cancer)
07/2004 - 02/2003
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2003 - 10/2002
1Experimental Arthritis
06/2021
1Amyloidosis
04/2021
1Amyloid Plaque
04/2021
1Heart Failure
04/2021
1Chronic Renal Insufficiency
01/2019
1Atrophy
01/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2018
1Hemorrhage
11/2018
1Stomach Neoplasms (Stomach Cancer)
04/2018
1Rectal Neoplasms (Rectal Cancer)
08/2017
1Arthritis (Polyarthritis)
01/2017
1Tenosynovitis
01/2017
1Fever (Fevers)
08/2016
1Dermatomyositis (Dermatopolymyositis)
08/2016
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
08/2016
1Pneumothorax
11/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
04/2011
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
06/2010
1Multiple Endocrine Neoplasia Type 1
01/2010
1Gastrinoma
01/2010
1Neoplasms, Cystic, Mucinous, and Serous
11/2009
1Hypercholesterolemia
09/2009
1Hyperlipidemias (Hyperlipidemia)
09/2009
1Hyperlipoproteinemias
09/2009
1Proteinuria
09/2009
1Internal Hernia
07/2008

Drug/Important Bio-Agent (IBA)

9Valosin Containing ProteinIBA
11/2005 - 02/2003
6NF-kappa B (NF-kB)IBA
08/2004 - 02/2003
4hepatoma-derived growth factorIBA
07/2007 - 01/2006
3beta CateninIBA
05/2006 - 03/2003
3Indicators and Reagents (Reagents)IBA
01/2004 - 02/2003
3Proteins (Proteins, Gene)FDA Link
01/2004 - 01/2003
2Methotrexate (Mexate)FDA LinkGeneric
02/2007 - 05/2006
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2006 - 01/2006
2Mitogen-Activated Protein Kinase 3IBA
05/2006 - 04/2004
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
05/2006 - 04/2004
2ParaffinIBA
05/2006 - 01/2004
2SteroidsIBA
08/2004 - 12/2002
2Peptides (Polypeptides)IBA
07/2004 - 01/2004
1geldanamycinIBA
06/2021
1Etanercept (Enbrel)FDA Link
06/2021
1Biological ProductsIBA
06/2021
1Type I Tumor Necrosis Factor ReceptorsIBA
06/2021
1Therapeutic UsesIBA
06/2021
1Tumor Necrosis Factor InhibitorsIBA
06/2021
1Prealbumin (Transthyretin)IBA
04/2021
1Congo RedIBA
04/2021
1Amyloidogenic ProteinsIBA
04/2021
1MineralsIBA
01/2019
1Parathyroid Hormone (Parathormone)IBA
01/2019
1Fibroblast Growth Factor-23IBA
01/2019
1Alkaline PhosphataseIBA
01/2019
1S-1 plus cisplatinIBA
04/2018
1Rheumatoid FactorIBA
01/2017
1Etoposide (VP 16)FDA LinkGeneric
08/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2016
1Rituximab (Mabthera)FDA Link
01/2013
1Immunoglobulin M (IgM)IBA
11/2012
1Cisplatin (Platino)FDA LinkGeneric
04/2011
1somatostatin receptor 2IBA
01/2010
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2010
1Octreotide (Sandostatin)FDA LinkGeneric
01/2010
1Capsules (Microcapsules)IBA
11/2009
1Immunoglobulin G (IgG)IBA
09/2009
1ApolipoproteinsIBA
09/2009
1Apolipoproteins E (ApoE)IBA
09/2009
1Dihydrotachysterol (AT 10)IBA
09/2009
1LipidsIBA
09/2009
1Interleukin-6 (Interleukin 6)IBA
09/2009
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2009
1Anti-Bacterial Agents (Antibiotics)IBA
07/2008

Therapy/Procedure

6Therapeutics
04/2018 - 08/2004
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2016 - 03/2002
2Colectomy
06/2010 - 01/2003
2Transplantation
09/2004 - 03/2002
2Immunotherapy
08/2004 - 07/2004
1Radiotherapy
11/2018
1Debridement
11/2018
1Drug Therapy (Chemotherapy)
04/2018
1Lymph Node Excision (Lymph Node Dissection)
08/2017
1Sternotomy
02/2011
1Pancreatectomy
11/2009